Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Feb 22, 2024
Net Buying
Open-Market Buys
$69K
Open-Market Sells
$0
Net Open-Market Flow
$69K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 22, 2024Buy(P)5K$0.90$5K927K
Feb 21, 2024Buy(P)22K$0.90$20K922K
Feb 20, 2024Buy(P)50K$0.88$44K900K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-016223) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML